ZANTE GREG (Chief Financial Officer) sold 52.3% of their position (161.94K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.78M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+32K
Price / share
$8.52
Trade value
$272.64K
% of position
Common Stock, par value $0.00001 per share
Shares
+42K
Price / share
$7.69
Trade value
$322.98K
% of position
Common Stock, par value $0.00001 per share
Shares
+12.25K
Price / share
$4.65
Trade value
$56.96K
% of position
Common Stock, par value $0.00001 per share
Shares
+7.50K
Price / share
$4.12
Trade value
$30.90K
% of position
Common Stock, par value $0.00001 per share
Shares
−131.03K
Price / share
$17.00
Trade value
$2.23M
% of position
Common Stock, par value $0.00001 per share
Shares
+30.91K
Price / share
$7.77
Trade value
$240.18K
% of position
Common Stock, par value $0.00001 per share
Shares
−30.91K
Price / share
$18.00
Trade value
$556.40K
% of position
Common Stock, par value $0.00001 per share
Shares
+56.67K
Price / share
—
Trade value
—
% of position
Common Stock, par value $0.00001 per share
Shares
−55.17K
Price / share
$17.57
Trade value
$969.27K
% of position
Net shares
−35.78K
Net value
-$2.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 3/30/2023 | M · Option Exercise | +32K | $8.52 | $272.64K | 17.3% | 185.06K | 217.06K |
| Common Stock, par value $0.00001 per share Direct | 3/30/2023 | M · Option Exercise | +42K | $7.69 | $322.98K | 19.3% | 217.06K | 259.06K |
| Common Stock, par value $0.00001 per share Direct | 3/30/2023 | M · Option Exercise | +12.25K | $4.65 | $56.96K | 4.7% | 259.06K | 271.31K |
| Common Stock, par value $0.00001 per share Direct | 3/30/2023 | M · Option Exercise | +7.50K | $4.12 | $30.90K | 2.8% | 271.31K | 278.81K |
| Common Stock, par value $0.00001 per share Direct | 3/30/2023 | S · Sale | −131.03K | $17.00 | $2.23M | 47.0% | 278.81K | 147.78K |
| Common Stock, par value $0.00001 per share Direct | 4/3/2023 | M · Option Exercise | +30.91K | $7.77 | $240.18K | 20.9% | 147.78K | 178.69K |
| Common Stock, par value $0.00001 per share Direct | 4/3/2023 | S · Sale | −30.91K | $18.00 | $556.40K | 17.3% | 178.69K | 147.78K |
| Common Stock, par value $0.00001 per share Direct | 4/3/2023 | A · Award | +56.67K | — | — | 38.3% | 147.78K | 204.44K |
| Common Stock, par value $0.00001 per share Direct | 4/3/2023 | F · Tax Withholding | −55.17K | $17.57 | $969.27K | 27.0% | 204.44K | 149.28K |
| Total | −35.78K | -$2.83M | ||||||
Stock Option (right to buy)
Common Stock
32K shares
Shares
−32K
Strike price
8.52
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
42K shares
Shares
−42K
Strike price
7.69
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
12.25K shares
Shares
−12.25K
Strike price
4.65
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
7.50K shares
Shares
−7.50K
Strike price
4.12
Held after
0.00
Exercisable
—
Stock Option (right to buy)
Common Stock
30.91K shares
Shares
−30.91K
Strike price
7.77
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock32K shares | 3/30/2023 | M · Option Exercise | −32K | 8.52 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock42K shares | 3/30/2023 | M · Option Exercise | −42K | 7.69 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock12.25K shares | 3/30/2023 | M · Option Exercise | −12.25K | 4.65 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock7.50K shares | 3/30/2023 | M · Option Exercise | −7.50K | 4.12 | — | 0.00 |
| Stock Option (right to buy) Direct | Common Stock30.91K shares | 4/3/2023 | M · Option Exercise | −30.91K | 7.77 | — | 0.00 |